Mycobacterium tuberculosis toxin Rv2872 is an RNase involved in vancomycin stress response and biofilm development
Bacterial toxin–antitoxin (TA) systems are emerging important regulators of multiple cellular physiological events and candidates for novel antibiotic targets. To explore the role of Mycobacterium tuberculosis function, unknown toxin gene Rv2872 was heterologously expressed in Mycobacterium smegmatis (MS_Rv2872). Upon induction, MS_Rv2872 phenotype differed significantly from the control, such as increased vancomycin resistance, retarded growth, cell wall, and biofilm structure. This phenotype change might result from the RNase activity of Rv2872 as purified Rv2872 toxin protein can cleave the products of several key genes involved in abovementioned phenotypes. In summary, toxin Rv2872 was firstly reported to be a endonuclease involved in antibiotic stress responses, cell wall structure, and biofilm development.
KeywordsToxin–antitoxin (TA) Antimicrobial resistance Biofilm RNase
We thank Professor Huang Hairong of Beijing Thoracic Hospital for providing the M. tuberculosis H37Rv genomic DNA and Professor Li Hongtao at School of Life Sciences, Southwest University, for the Western blot experiment support. This work was supported by National Natural Science Foundation (81371851, 81071316, 81271882, 81301394, 81172806, 81471563), National key R & D plan (2016YFC0502304), the Fundamental Research Funds for the Central Universities (XDJK2017D101, XDJK2017D100, XDJK2017D099) and Chongqing Municipal Education Science foundation (2015-JC-020).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any other authors.
- Ahidjo BA, Kuhnert D, Mckenzie JL, Machowski EE, Gordhan BG, Arcus V, Abrahams GL, Mizrahi V (2011) VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins. PLoS One 6(6):e21738CrossRefPubMedPubMedCentralGoogle Scholar
- Albrethsen J, Agner J, Piersma SR, Højrup P, Pham TV, Weldingh K, Jimenez CR, Andersen P, Rosenkrands I (2013) Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin–antitoxin systems. Mol Cell Proteomics 12(5):1180–1191CrossRefPubMedPubMedCentralGoogle Scholar
- Cook GM, Robson JR, Frampton RA, Mckenzie J, Przybilski R, Fineran PC, Arcus VL (2013) Ribonucleases in bacterial toxin-antitoxin systems. BB 1829(6–7):523Google Scholar
- Duan X, Li Y, Du Q, Huang Q, Guo S, Xu M, Lin Y, Liu Z, Xie J (2015) Mycobacterium lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level. Sci RepGoogle Scholar
- Dye C, Brian G. Williams, Marcos A. Espinal, Raviglione MC (2002) Erasing the world’s slow stain strategies to beat multidrug-resistant tuberculosis. ScienceGoogle Scholar
- Luo H, Zeng J, Huang Q, Liu M, Abdalla AE, Xie L, Wang H, Xie J (2015) Mycobacterium tuberculosis Rv1265 promotes mycobacterial intracellular survival and alters cytokine profile of the infected macrophage. J Biomol Struct Dyn 34(3):585Google Scholar
- Matsumiya Y, Murata N, Tanabe E, Kubota K, Kubo M (2009) Characterization of the interaction and cross-regulation of three Mycobacterium tuberculosis RelBE modules. PLoS One 5(5):e10672Google Scholar
- Melderen LV, Bast MSD (2009) Bacterial toxin–antitoxin systems: more than selfish entities? PLoS Genet 5(3):135–139Google Scholar
- Pullinger GD, Lax AJ (1992) A Salmonella dublin virulence plasmid locus that affects bacterial growth under nutrient-limited conditions. Mol Microbiol 6(12):1631–1643Google Scholar
- Roberta Provvedi FB, Francesco Falciani, Giorgio Palù, Manganelli AR (2009) Global transcriptional response to vancomycin in Mycobacterium tuberculosis. MicrobiolGoogle Scholar
- Soetaert K, Rens C, Wang XM, De BJ, Lanéelle MA, Laval F, Lemassu A, Daffé M, Bifani P, Fontaine V (2015) Increased vancomycin susceptibility in mycobacteria: a new approach to identify synergistic activity against multidrug-resistant mycobacteria. Antimicrob Agents Chemother 59(8):5057–5060CrossRefPubMedPubMedCentralGoogle Scholar
- Zeng J, Deng W, Yang W, Luo H, Duan X, Xie L, Li P, Wang R, Fu T, Elgaili AA (2016) Mycobacterium tuberculosis Rv1152 is a novel GntR family transcriptional regulator involved in intrinsic vancomycin resistance and is a potential vancomycin adjuvant target. Sci RepGoogle Scholar